This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Phosphatidylserine
The single most evidence-backed sleeper pick for exercise-induced cortisol blunting in athletes — a multi-decade Monteleone/Starks/Fahey series shows 600-800 mg/day PS reduces post-exercise cortiso…
Aliases (1)
Overview
What is Phosphatidylserine?
The single most evidence-backed sleeper pick for exercise-induced cortisol blunting in athletes — a multi-decade Monteleone/Starks/Fahey series shows 600-800 mg/day PS reduces post-exercise cortisol AUC by ~30-35% and improves testosterone:cortisol ratio. Underrated for a high-volume training athlete + business operator with HPA load. Modern supplements are soy- or sunflower-derived (not bovine — pulled mid-1990s over BSE concern). Cognition signal is real in age-associated decline but smaller in young healthy adults. Sweet spot for a Dylan-profile athlete: 600 mg/day split 300 mg AM + 300 mg pre-training (4-6×/week on training days), 300 mg/day on rest days. ~$0.30-0.50 per 300 mg cap; not cheap relative to magnesium glycinate, but cheap relative to its mechanistic reach.
Research Indications
Membrane fluidity and curvature
PS asymmetry is maintained by ATP-dependent flippases; loss of asymmetry (PS exposure on outer leaflet) is the canonical "eat-me" apoptos…
Anchor for signaling-protein translocation
Akt, Raf-1, and PKCα all require electrostatic interaction with inner-leaflet PS to translocate from cytosol and become catalytically act…
SNARE-mediated synaptic vesicle release
PS binds synaptotagmin-1's C2 domains in Ca²⁺-dependent vesicle fusion. Reduced membrane PS = sluggish neurotransmitter release.
Bovine cortex PS (BC-PS)
used in all classic 1990s trials. Naturally enriched in DHA at the sn-2 position (~30-40% DHA content). DHA-PS species are arguably the b…
Soy-derived PS (S-PS)
current market standard since mid-1990s. Made by transphosphatidylation of soy lecithin. Contains predominantly linoleic acid and palmiti…
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
Best pairing. Different mechanism — ashwagandha modulates peripheral cortisol synthesis (adrenal level) + has mild GABAergic action; PS modulates central CRH…
Adaptogen with mixed monoaminergic + HPA effects. Compatible — different mechanism, no redundancy. Stack works for the high-stress athlete profile.
Neutral co-administration; magnesium supports HPA regulation independently. No interaction.
Important synergy — DHA co-administration approximates the bovine-PS molecular species (DHA-rich) using a soy-PS base. Some research-grade products (e.g., Li…
Compatible. Different anxiolytic/HPA mechanisms.
Synergistic on cognitive endpoint — both support cholinergic membranes; PS supports cholinergic-receptor membrane environment.
Neutral; potential additive cognitive support but no direct interaction.
(prednisone, etc.) — theoretical antagonism on HPA-feedback; clinical relevance unstudied. Discuss with prescriber.
(metyrapone, mifepristone): redundant + theoretical over-suppression. Not relevant for Dylan archetype.
if a user is already running ashwagandha 600 mg + rhodiola 400 mg + low-intensity training + chronic stress relief practices, adding 600 mg PS can produce fl…
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 6
Side Effects
- 1GI upset / loose stool — most common AE; often from soy-PS phospholipid load. Mitigation: switch to sunflower-derived PS, split dose with meals, reduce dose.
- 2Mild stimulation / restlessness — paradoxical, when PS over-blunts morning cortisol without enough adrenergic backstop. Resolves with dose reduction or AM-only dosing.
- 3Insomnia if dosed too late evening (>7 PM) at >200 mg
- 4Headache (~5% in trials, usually transient first week)
- 5Mild fatigue (subset of users who over-flatten daytime cortisol — corrects with dose reduction)
- 6"Emotional flatness" reported anecdotally — typically in users already on ashwagandha + rhodiola + low training; over-dampening the HPA axis becomes a downside
When to Stop
- No serious adverse events documented in clinical trials at 100-800 mg/d for up to 6-12 months. Modern soy-PS has a Generally Recognized as Safe (GRAS) profile.
- Historical BSE risk (bovine-cortex PS) is no longer a concern — bovine-derived PS was voluntarily withdrawn from the US/EU market in the mid-1990s during the mad-cow scare. Modern soy- or sunflower-derived PS carries zero prion-transmission risk. When interpreting older trials (Crook 1991, Monteleone 1990/1992), remember they were done with BC-PS — the bovine-DHA-PS molecular species. Modern soy-PS may not replicate cognitive endpoints as cleanly (sn-2 DHA missing). HPA endpoints do replicate.
- Soy allergy — soy-PS contraindicated. Use sunflower-derived (Sharp-PS Green or equivalent).
- Week 1-2: GI tolerance check. If loose stool persists, switch to sunflower-PS or reduce to 300 mg/d.
- Week 2-4: paradoxical stimulation watch. If feeling more wired (not less), drop evening dose or switch to AM-only.
- Month 1-2: mood/flatness watch. If layered onto already-low-cortisol stack (ashwagandha + rhodiola + low training), watch for hypocortisolism-like flatness, fatigue, low motivation. Test salivary cortisol curve if suspicious.
- Bovine-derived PS — DO NOT BUY even if it appears on niche supplement sites. Reliable manufacturers do not source bovine PS in 2026. Verify "soy lecithin-derived" or "sunflower lecithin-derived" on the label.
References
Monteleone et al. 1990 — Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans
first mechanistic IV-PS demonstration; 50/75 mg BC-PS blunted ACTH/cortisol to exercise. Neuroendocrinology 52(3):243-8.
View StudyMonteleone et al. 1992 — Blunting by chronic phosphatidylserine administration of the stress-induced activation of the HPA axis in healthy men
oral 800 mg/d × 10 d BC-PS blunted ACTH and cortisol response to physical exercise. Eur J Clin Pharmacol 42(4):385-8.
View StudyStarks et al. 2008 — The effects of phosphatidylserine on endocrine response to moderate-intensity exercise
600 mg/d soy-PS × 10 d; peak cortisol ↓39%, T:C ratio ↑184%. The Dylan-protocol anchor study. J Int Soc Sports Nutr 5:11.
View StudyFahey & Pearl 1998 — The hormonal and perceptive effects of phosphatidylserine administration during two weeks of weight training-induced overtraining
800 mg/d S-PS reduced post-exercise cortisol, attenuated soreness in resistance overtraining. Biology of Sport 15:135-44.
View StudyHellhammer et al. 2014 — A soy-based phosphatidylserine/phosphatidic acid complex normalizes HPA reactivity in chronically stressed men
PAS 400 mg × 42 d in n=72; effective only in high-stress subgroup; state-dependence established. Lipids Health Dis 13:121.
View StudyHellhammer et al. 2004 — Effects of soy lecithin PA/PS complex on TSST-induced HPA reactivity
400/600/800 mg PAS pre-Trier Social Stress Test. Stress 7(2):119-26.
View StudyCrook et al. 1991 — Effects of phosphatidylserine in age-associated memory impairment
100 mg BC-PS tid × 12 w in 149 patients; improved learning/memory, largest in lower-baseline subgroup. Neurology 41(5):644-9.
View StudyCrook et al. 1992 — Effects of phosphatidylserine in Alzheimer's disease
BC-PS in AD; cognitive improvement greater in less-impaired patients.
View StudyEngel et al. 1992 — Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type
Eur Neuropsychopharmacol.
View StudyKato-Kataoka et al. 2010 — Soybean-derived phosphatidylserine improves memory function of elderly Japanese subjects with memory complaints
modern soy-PS replication of cognitive signal in low-baseline subgroup. J Clin Biochem Nutr 47(3):246-55.
View StudyDuan et al. 2025 — Food supplement containing phosphatidylserine improves cognition in Chinese MCI
12-mo RCT, n=190; arithmetic, similarity, short-term memory improved. Combo formula. J Affect Disord.
View StudyBenton et al. 2001 — Influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor
300 mg/d × 1 mo in young adults; mood improvement in high-neuroticism subgroup. Nutr Neurosci 4(3):169-78.
View StudyJäger et al. 2007 — The effect of phosphatidylserine on golf performance
200 mg/d × 42 d in 20 amateur golfers; improved performance, trend on stress (p=0.07). Nutr J 6:23.
View StudyKingsley et al. 2005 — Effects of phosphatidylserine on oxidative stress following intermittent running
750 mg/d × 10 d; null on cortisol, modest ergogenic signal. Med Sci Sports Exerc.
View StudyKingsley et al. 2006 — Effects of phosphatidylserine on exercise capacity during cycling in active males
TTE improvement; cortisol null. Med Sci Sports Exerc 38(1):64-71.
View StudyKingsley 2006 — Effects of phosphatidylserine supplementation on exercising humans (review)
Kingsley's own narrative review. Sports Med 36(8):657-69.
View StudyHellhammer et al. 2012 — Omega-3 fatty acids administered in PS improved aspects of high chronic stress in men
PS-O3 normalized cortisol response in high-stress subgroup. Nutr Res 32(4):241-50.
View StudyHirayama et al. 2014 — Effect of phosphatidylserine administration on memory and symptoms of ADHD
200 mg/d soy-PS × 2 mo in 36 children 4-14 y; improved ADHD symptoms and short-term memory. J Hum Nutr Diet 27 Suppl 2:284-91.
View StudyManor et al. 2012 — Effect of phosphatidylserine + omega-3 on ADHD symptoms in children
200 children, PS-O3 combo; restless/impulsive subscale reduction. Eur Psychiatry 27(5):335-42.
View StudyBruton et al. 2021 — Phosphatidylserine for pediatric ADHD: systematic review and meta-analysis
4 studies n=344; SMD 0.36 inattention (p=0.01); low-quality evidence. J Altern Complement Med 27(4):312-22.
View StudyMa et al. 2022 — Phosphatidylserine, inflammation, and central nervous system diseases
Front Aging Neurosci review of PS roles in AD, PD, MDD, ADHD, autism.
View StudyHuang et al. 2011 — Phosphatidylserine is a critical modulator for Akt activation
molecular basis of PS-dependent Akt translocation. J Cell Biol.
View StudyKim et al. 2014 — Phosphatidylserine in the brain: metabolism and function
Prog Lipid Res comprehensive PS metabolism/function review.
View StudyFDA qualified health claim letter for phosphatidylserine and cognitive dysfunction (2003)
FDA-issued qualified health claim status.
View StudyPhosphatidylserine — Wikipedia 2026
general reference; bovine→soy historical transition, PS biology.
View StudyLatest research
- rctFood supplement containing phosphatidylserine improves cognition in Chinese older adults with MCI12-month RCT (n=190) of PS-containing supplement improved arithmetic, similarity testing, and short-term memory in mild cognitive impairment.
- reviewPhosphatidylserine, inflammation, and central nervous system diseasesFrontiers Aging Neuroscience review of PS roles in AD, PD, MDD, ADHD, autism — mechanism via synaptotagmin, membrane signaling, immune clearance.
- metaPhosphatidylserine for pediatric ADHD — systematic review and meta-analysis4 studies (n=344); SMD 0.36 inattention (p=0.01), null on hyperactivity. "Preliminary low-quality evidence" at 200-300 mg/day.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.